Releases

Date	Title
Feb 19 2021	Year-end report
Feb 05 2021	Further Study supports use of Nevisense within new Non-melanoma Skin Cancer application
Feb 03 2021	The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2021:
Dec 08 2020	New Study published validating further Nevisense indication, Non-melanoma Skin Cancer
Nov 12 2020	Interim report
Nov 04 2020	SciBase announces changes to the Management team
Nov 02 2020	Positive step for US reimbursement of Nevisense
Oct 30 2020	SciBase releases next generation platform, Nevisense Go.
Oct 21 2020	SciBase Holding AB announces the outcome of the exercise of warrants of series TO1
Oct 02 2020	Exercise price for warrants of series TO1 in SciBase Holding AB determined and the subscription period commence on 5 October 2020

Press releases